Skip to content

Comparison of the Effects of Lidocaine and Articaine Used for Buccal Infiltration and Supplemental Palatinal Infiltration Anesthesia in Teeth With Irreversible Pulpitis

Comparison of the Effects of Lidocaine and Articaine Used for Buccal Infiltration and Supplemental Palatinal Infiltration Anesthesia in Teeth With Irreversible Pulpitis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06342869
Enrollment
80
Registered
2024-04-02
Start date
2022-04-01
Completion date
2022-12-01
Last updated
2024-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fist and Second Molars With ırreversible Pulpitis

Keywords

articaine, lidocaine, irreversible pulpitis, infiltration anesthesia

Brief summary

Objective: The aim of this study was to compare the effects of articaine or lidocaine in buccal infiltration or palatal infiltration in addition to buccal infiltration in maxillary first or second molars with irreversible pulpitis. Method: Among the patients who applied to Akdeniz University Faculty of Dentistry Endodontic Clinic for the treatment of maxillary molars with irreversible pulpitis, 80 volunteers who met the criteria were included in the study. Eighty patients were divided into 4 groups (n = 20). 1. group buccal infiltration with 4% articaine containing 1:100,000 epinephrine, 2. group buccal infiltration with 2% lidocaine containing 80,000 epinephrine, 3. group buccal and palatinal infiltration with 4% articaine containing 1:100,000 epinephrine, 4.group buccal and palatinal infiltration with 2% lidocaine containing 80.000 epinephrine. Pain during the endodontic procedure was determined and recorded according to the Heft Parker visual analog scale.

Interventions

PROCEDUREAnesthesia

application of different anesthesia techniques

Sponsors

Akdeniz University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

1. The patient must be a healthy individual between the ages of 18 and 65 who is classified as ASA I and II. 2. No allergy to local anesthetic substances to be used in the study 3. Upper maxillary molars with irreversible pulpitis whose vitality has been proven by pulp tests, with no radiolucency at the root tip 4. Not having used any painkillers, antibiotics, antidepressants and sedative drugs in the last 12 hours 5. Being capable of understanding the Pain scale

Exclusion criteria

1. Allergy to local anesthetics 2. Failure to respond to the cold test and electric pulp test performed on the relevant tooth 3. Radiolucent lesion in the apical part of the relevant tooth on periapical radiography 4. No vital tissue is encountered when the pulp chamber is opened

Design outcomes

Primary

MeasureTime frame
Assessment of complementary palatinal anesthesia with VAS10 minutes after anesthesia is performed

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026